Tuberc Respir Dis > Volume 63(4); 2007 > Article
Tuberculosis and Respiratory Diseases 2007;63(4):362-367.
DOI: https://doi.org/10.4046/trd.2007.63.4.362    Published online October 1, 2007.
Pulmonary Thromboembolism after Post-menopause Hormonal Replacement Therapy.
Sun Young Kim, Jong Hyeok Park, Hyun Kyung Lee, Hyuk Pyo Lee, Hye Kyung Lee, Soo Jeon Choi, Ho Kee Yum
1Department of Internal Medicine, Inje University, Seoul, Korea. pulho@korea.com
2Department of Pathology, Inje University, Seoul, Korea.
Abstract
Hormonal replacement therapy (HRT) has been proven for treatment of postmenopausal symptoms such as hot flushes, night sweats and urologic symptoms. HRT became very popular in the 1990's, when there were several reports showing that it also helped with other menopausal complications such as osteoporosis and cardiovascular disease. Recent studies report that the incidence of breast cancer, endometrial cancer, cerebral infarction, coronary artery diseases, deep vein thrombosis and pulmonary thrombembolism could rise after HRT. Among these side effects of HRT, the risk of pulmonary thromboembolism increases 2 to 4 fold after HRT, but can vary with the use of different doses and preparations. Here, we summarize the risk factors and clinical courses for 5 patients who developed pulmonary thromboembolism after postmenopausal HRT.
Key Words: Postmenopause hormone replacement therapy(HRT), Pulmonary thromboembolism, Deep vein thrombosis


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next